Angioplasty Summit 2004 > Syllabus

Welcome
Course Director
Hot Topic
Invited Faculty
Meeting at a
Glance
Program
Abstracts
Poster Abstracts -
Guideline -
Syllabus
Factoid
Expert Lectures
Gallery 2004
Hotel
Accommodations
Exhibition
Sights of Korea
Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution.
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
Stem cell repair of infarcted myocardium: an overview for clinicians.
Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study.
Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy.
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia.
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.
Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation.
Adult stem cell therapy in perspective.
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
Aging, progenitor cell exhaustion, and atherosclerosis.
Progenitor and embryonic stem cell transplantation for myocardial angiogenesis and functional restoration.
Stem cell therapy in perspective.
Endothelial progenitor cells: new hope for a broken heart.
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia.